1. 1
    AMAT

    Applied Materials shares gain on Q4 beat

    • 📈 AMAT shares rose 1.5% after Q4 earnings beat analyst expectations.
    • 💰 Adjusted EPS hit $4.16, topping the $4.06 consensus estimate.
    • 💵 Revenue reached $10.41 billion, exceeding the $10.3 billion forecast.
    • 🚀 Semiconductor Systems business targets over 40% growth in calendar 2026.
  2. 4
    MET

    MetLife stock posts record Q3 adjusted EPS as growth spans segments

    • 📈 MetLife Q3 adjusted EPS rose 22% to $2.85 excluding notable items.
    • 💰 Revenue grew 12% to $14.1 billion across all six business segments.
    • 📊 Adjusted return on equity hit 19.6%, surpassing analyst expectations.
    • 💸 Company returned ~$1 billion to shareholders via buybacks and dividends.
  3. 5
    LLY

    Eli Lilly (LLY) Stock Climbs as China Approves First GLP-1 Weight-Loss Pill

    • 🚀 Eli Lilly stock surged 3% to a record high after China approved orforglipron (Foundayo).
    • 🏆 Foundayo approval positions Lilly ahead of Novo Nordisk for oral GLP-1 clearance in China.
    • 💊 The new therapy offers a once-daily, non-injection alternative appealing to patients avoiding needles.
    • 💰 Strong Q3 revenue of $24.4 billion was driven by Mounjaro and Zepbound sales growth.
  4. 6
    ITW

    Illinois Tool Works stock lifts 2026 outlook after Q3 margin gain

    • 📈 ITW Q3 revenue grew 4.4% to $4.236 billion led by North America.
    • 💰 Operating income hit record $1.177 billion with margins expanding to 27.8%.
    • 🚀 Management raised full-year EPS guidance to $11.45-$11.55, implying 10% growth.
    • 💵 Free cash flow reached $851 million with a perfect 100% conversion rate.
  5. 10
    MNST

    Monster Beverage stock faces margin test after record sales

    • 📈 Monster Q3 net revenue surged 16.7% to $2.56 billion.
    • 🌍 International sales jumped 28.1%, now accounting for 47% of revenue.
    • 📉 Gross margins fell to 54.7% due to higher can and freight costs.
    • 💰 Monster repurchased $100 million in shares, buying back 2.3 million units.
  6. 12
    ORCL

    Is There Hope for Oracle After Plummeting 35% This Year? ‘Yes’ Says One Analyst Predicting 210% Gains From Here

    • 📉 ORCL shares down 35% YTD amid negative free cash flow and heavy financing needs.
    • 💰 Company raised $20 billion recently with interest expenses climbing 55% to $1.4 billion.
    • 📈 OCI revenue surged 121% last quarter as backlog grew $209 billion year-over-year.
    • 🤖 Management expects half of $664B backlog to convert into sales over next 36 months.
  7. 13
    DELL

    Was The Run In Dell Stock Hiding In Plain Sight?

    • 📈 Dell shares surged 39.0% May-November 2025 on strong data center demand signals.
    • 💰 Revenue accelerated to 39.5% YoY, reaching $47.0 billion by July 2026.
    • 🖥️ Infrastructure Solutions Group hit record $31.8 billion revenue in Q3 fiscal 2026.
    • 🤖 AI servers dominated with $16.4 billion revenue and a $95 billion backlog.
  8. 14
    ELV

    Elevance Health stock enters 2027 with Medicaid recovery in focus

    • 📈 Elevance Health raised 2026 EPS guidance to $29.00 after strong Q3 results.
    • 💰 Q3 adjusted EPS reached $6.99 with operating revenue growing 0.7% year over year.
    • 🚀 Management targets at least 12% adjusted earnings growth for 2027 from $26.75 baseline.
    • 🏥 Benefit expense ratio improved 70 bps to 90.6% driven by Medicare Advantage and ACA.
  9. 17
    GWW

    W.W. Grainger stock faces execution test after higher 2026 outlook

    • 📈 Q3 sales surged 11.3% to $5.181 billion with strong volume growth.
    • 🚀 Daily organic constant-currency sales expanded 14.9% driven by price inflation.
    • 💰 Operating earnings jumped 62.0% to $828 million aided by prior-year comparison.
    • 🎯 Full-year 2026 sales guidance raised to $19.8B-$20.0B range.
  10. 18
    MMM

    3M stock faces $5.8 billion PFAS charge as buyback expands

    • 📉 3M settles ~99% PFAS claims for $7.35B nominal commitment over nine years.
    • ⚖️ Settlement covers 115,000 to 120,000 plaintiffs without admitting liability.
    • 💰 Company records $5.8B pre-tax charge in Q4 2026 while retaining full-year guidance.
    • 🔄 Agreement substantially reduces legacy litigation uncertainty per CEO William Brown.
  11. 19
    AMGN

    Is Amgen Stock Priced Right Against Its Peers?

    • 📊 AMGN ranks second among six major drugmakers in revenue growth and operating margins.
    • 💰 Investors pay 27x earnings for AMGN versus 42x for Johnson & Johnson.
    • 🚀 Six core medicines drove a 27% year-over-year growth in product sales.
    • 💊 Repatha generated $1.1 billion quarterly revenue with a 37% increase.
  12. 21
    FANG

    Diamondback Energy stock gains focus from output and dividend

    • 📈 Diamondback raised 2026 oil guidance to 524,000 barrels per day.
    • 💰 Q3 revenue hit $5.431 billion with net income of $1.603 billion.
    • 🛢️ Total production guidance increased to 1.015 million barrels of oil equivalent.
    • 💵 Quarterly dividend rose 7.3% to $1.18; annual base is $4.72.
  13. 24
    KEY

    Higher Rates and Industry Tailwinds: 3 Major Regional Banks to Watch

    • 📈 KeyCorp identified as major regional bank well-positioned for higher rates and economic growth.
    • 💰 Steady top-line growth driven by loan expansion and diversified fee income streams.
    • 📊 Revenues grew 2.3% CAGR over last five years from rising non-interest and net interest income.
    • 💵 Raised quarterly cash dividend 5.1% in 2022 to 20.5 cents per share, maintained since.
  14. 25
    NOC

    Northrop Grumman stock sees stronger international growth path

    • 🚀 Northrop Grumman expects 5-7% sales growth through 2028.
    • 🌍 International sales projected to exceed $10 billion by 2031.
    • 🛰️ National security space now represents over 15% of sales.
    • 💰 Capital spending planned at 4.5% of sales in 2027-2028.
  15. 26
    MSCI

    Strategy Made $19.5 Billion in Profit. So Why Is MSCI Removing It From Stock Indexes?

    • 📉 MSCI removed MicroStrategy from major indexes due to non-operating classification rules.
    • 💰 Nearly all income came from Bitcoin accounting changes, not software revenue.
    • 📊 Software revenue declined 3% year-over-year while total annual revenue dropped below pre-Bitcoin levels.
    • 📉 ~13 million shares (3.1%) held by index funds face immediate selling pressure upon removal.
  16. 27
    NDAQ

    Nasdaq Stock: Analyst Estimates & Ratings

    • 📈 NDAQ shares rose 7.5% on Q3 revenue up 13% to $1.48 billion.
    • 💰 Adjusted EPS climbed 18.2% to $1.04 with record recurring revenue of $3.4 billion.
    • 👍 Analyst consensus is "Strong Buy" with 14 of 21 ratings supporting the stock.
    • 🚀 Goldman Sachs raised price target to $120 citing strong FinTech growth and AI efficiencies.
  17. 28
    NEM

    Newmont stock faces higher 2027 spending as growth projects advance

    • 📈 Newmont expects gold production growth returning in 2027 as Tanami Expansion 2 advances.
    • ⛏️ Red Chris feasibility study nearing completion with investment decision anticipated early 2027.
    • 💰 Development capital projected to rise $500M in 2027, partially offset by Yanacocha spending cuts.
    • 🥇 Red Chris targets 3.0M ounces gold and 850k tonnes copper starting commercial production 2033.
  18. 29
    AXP

    American Express Sees 10% Revenue Growth as Platinum Card Renewals Hit 99%

    • 📈 AXP expects ~10% revenue growth and mid-teens EPS growth driven by premium spending.
    • 💳 Platinum Card renewals hit ~99%, reinforcing dominance in the premium market.
    • ✈️ Total cardholder spending grew 8%, with travel/entertainment up 10% and airline up 13%.
    • 🤖 AXP integrates AI with partners for reservations, fraud prevention, and customer service calls.